Waters (NYSE:WAT – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 2.170-2.250 for the period, compared to the consensus EPS estimate of 2.430. The company issued revenue guidance of $643.2 million-$662.3 million, compared to the consensus revenue estimate of $673.6 million. Waters also updated its FY 2025 guidance to 12.700-13.000 EPS.
Waters Trading Down 1.2 %
WAT traded down $4.46 during trading on Thursday, reaching $377.45. 46,524 shares of the company’s stock were exchanged, compared to its average volume of 428,892. The company’s fifty day moving average price is $390.16 and its 200-day moving average price is $363.86. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. Waters has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The firm has a market capitalization of $22.41 billion, a PE ratio of 36.16, a P/E/G ratio of 7.37 and a beta of 1.01.
Waters (NYSE:WAT – Get Free Report) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.43% and a return on equity of 49.93%. As a group, equities analysts forecast that Waters will post 11.79 EPS for the current year.
Analyst Upgrades and Downgrades
View Our Latest Research Report on Waters
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
- Five stocks we like better than Waters
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- What is the FTSE 100 index?
- CVS Health: Earnings Beat Ignites Stock Rally
- Most Volatile Stocks, What Investors Need to Know
- Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.